Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.28 USD
Change Today +0.04 / 3.23%
Volume 1.0M
PPHM On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark R. Schleiss M.D.

Member of Scientific Resource Board of Anti Viral CMV, Peregrine Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Dr. Mark R. Schleiss, MD serves as Professor and Associate Head for Research and American Legion Chairman in the Department of Pediatrics and Director, Division of Infectious Diseases at University of Minnesota. Dr. Schleiss has been a Member of CMV Advisory Board of Alphavax, Inc. since January 30, 2008. Dr. Schleiss serves as a Member of Scientific Resource Board of Anti-Viral- CMV at Peregrine Pharmaceuticals Inc.

Corporate Headquarters*

14282 Franklin Avenue
Tustin, California 92780

United States

Phone: 714-508-6000
Fax: 714-838-5817

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PPHM:US $1.28 USD +0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$964.7K
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Corporate Secretary and Director
GenVec, Inc.
$375.0K
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$821.0K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$555.7K
Stephen T. Isaacs Chairman, Chief Executive Officer and President
Aduro BioTech, Inc.
$886.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PEREGRINE PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.